Molecular Therapy-Oncolytics

Article	Citations
CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts	87
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect	84
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors	67
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism	66
Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia	65
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications	61
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer	58
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive Leukemia	57
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities	57
Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs	52
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B	52
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy	48
Carboranes as unique pharmacophores in antitumor medicinal chemistry	46
Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer	46
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?	46
Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy	45
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma	43
ENO1 and Cancer	43
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges	42
In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide	42
Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis	41
Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer	40
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer	40
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma	39
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma	38

Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways	37
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy	37
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor	37
CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease	37
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells	36
Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy	36
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation	36
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer	36
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy	35
The next wave of cellular immunotherapies in pancreatic cancer	35
Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression	34
Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer	34
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma	34
circRNA circFUT8 Upregulates Krüpple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p	34
Novel roles of METTL1/WDR4 in tumor via m7G methylation	33
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy	33
Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21	32
Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors	32
Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model	32
Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer	32
Angiogenesis-related non-coding RNAs and gastrointestinal cancer	32
The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients	32
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis	32
Chromosome Abnormalities: New Insights into Their Clinical Significance in Cancer	32
LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer	32
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives	31
Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts	31
m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer	30
SNHG1 knockdown upregulates miR-376a and downregulates FOXK1/Snail axis to prevent tumor growth and metastasis in HCC	30
Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma	30
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4	30
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy	29
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma	29
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice	29
NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer	28
BRD4: An emerging prospective therapeutic target in glioma	28
microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3/NFE2L2/TXNRD1 axis	28
Hypomethylation Causes MIR21 Overexpression in Tumors	28
SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF	28
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer	27
Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children	27
Annexin A8 regulated by lncRNA-TUG1/miR-140-3p axis promotes bladder cancer progression and metastasis	27
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model	27
miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression	27
m6A demethylase FTO induces NELL2 expression by inhibiting E2F1 m6A modification leading to metastasis of non-small cell lung cancer	26
A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer	26
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials	26
miR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer	26
Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling	25
Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells	25

Defueling the cancer: ATP synthase as an emerging target in cancer therapy	25
Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth	25
Systematic review of the immunological landscape of Wilms tumors	25
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges	25
Protein Palmitoylation Regulates Cell Survival by Modulating XBP1 Activity in Glioblastoma Multiforme	24
MGP Promotes Colon Cancer Proliferation by Activating the NF-κB Pathway through Upregulation of the Calcium Signaling Pathway	24
RETRACTED: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2	24
lncRNA DUXAP8 Facilitates Multiple Malignant Phenotypes and Resistance to PARP Inhibitor in HCC via Upregulating FOXM1	24
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model	24
Ginkgolic Acid, a SUMO-1 Inhibitor, Inhibits the Progression of Oral Squamous Cell Carcinoma by Alleviating SUMOylation of SMAD4	24
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?	24
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform	24
Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer	23
Systemic delivery of TNF-armed myxoma virus plus immune checkpoint inhibitor eliminates lung metastatic mouse osteosarcoma	23
Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma	23
Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9	23
miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential	23
Regulatory role and mechanism of m6A RNA modification in human metabolic diseases	22
Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency	22
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas	22
Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference	22
MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC	22
Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma	22
Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma	22
Histone Deacetylase Inhibitor Sensitizes ERCC1-High Non-small-Cell Lung Cancer Cells to Cisplatin via Regulating miR-149	22
In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2	22
Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma	21
WTAP Gene Variants Confer Hepatoblastoma Susceptibility: A Seven-Center Case-Control Study	21
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2	21
A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy	21
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism	21
Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation	21
Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma	20
Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2	20
The lncRNA DLGAP1-AS1/miR-149-5p/TGFB2 axis contributes to colorectal cancer progression and 5-FU resistance by regulating smad2 pathway	20
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin	20
Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis	20
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment	20
Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer	20
LRPPRC regulates metastasis and glycolysis by modulating autophagy and the ROS/HIF1-α pathway in retinoblastoma	20
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy	19
The PABPC5/HCG15/ZNF331 Feedback Loop Regulates Vasculogenic Mimicry of Glioma via STAU1-Mediated mRNA Decay	19
Molecular Targeting of Cancer-Associated PCNA Interactions in Pancreatic Ductal Adenocarcinoma Using a Cell-Penetrating Peptide	19
Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes	19
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy	19
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4	19
Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer	19
A Cereblon Modulator CC-885 Induces CRBN- and p97-Dependent PLK1 Degradation and Synergizes with Volasertib to Suppress Lung Cancer	19
The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer	19
miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway	18
Boosting Replication and Penetration of Oncolytic Adenovirus by Paclitaxel Eradicate Peritoneal Metastasis of Gastric Cancer	18
lncRNA MIR503HG inhibits cell proliferation and promotes apoptosis in TNBC cells via the miR-224-5p/HOXA9 axis	18
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE	18
Current strategies in engaging oncolytic viruses with antitumor immunity	18
A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b	18
Classification of pediatric gliomas based on immunological profiling: Implications for immunotherapy strategies	18
Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma	18
Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway	17
Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway	17
Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway	17
Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors	17
Efferocytosis and Its Associated Cytokines: A Light on Non-tumor and Tumor Diseases?	17
miR-324-5p Contributes to Cell Proliferation and Apoptosis in Pancreatic Cancer by Targeting KLF3	17
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer	17
CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells	17
Lactate Dehydrogenase A Depletion Alters MyC-CaP Tumor Metabolism, Microenvironment, and CAR T Cell Therapy	17
Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma	17
lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway	16
Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma	16
Imaging CAR T-cell kinetics in solid tumors: Translational implications	16
The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma	16
Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq	16
Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling	16
Extending traditional antibody therapies: Novel discoveries in immunotherapy and clinical applications	16
MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer	16
Wnt7a Counteracts Cancer Cachexia	16
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma	16
Progress and application of circulating tumor cells in non-small cell lung cancer	16
miR-155 Accelerates the Growth of Human Liver Cancer Cells by Activating CDK2 via Targeting H3F3A	16
Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis	16

Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo	16
Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients	16
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma	15
Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives	15
Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis	15
Circular RNAs act as regulators of autophagy in cancer	15
Circular RNA circRAB31 acts as a miR-885-5p sponge to suppress gastric cancer progression via the PTEN/PI3K/AKT pathway	15
Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment	15
oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity	15
Intracranial delivery of synthetic mRNA to suppress glioblastoma	15
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer	15
Circular RNA SERPINE2 promotes development of glioblastoma by regulating the miR-361-3p/miR-324-5p/BCL2 signaling pathway	15
GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17	15
Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer	15
AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines	15
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability	15
Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model	15
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer	15
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35	15
Upregulated CBX8 Promotes Cancer Metastasis via the WNK2/MMP2 Pathway	15
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy	14
UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis	14
IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma	14
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells	14
USMB-shMincle: a virus-free gene therapy for blocking M1/M2 polarization of tumor-associated macrophages	14
CRISPR-Cas knockout of miR21 reduces glioma growth	14
miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen	14
A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer	14
Silencing ZIC2 abrogates tumorigenesis and anoikis resistance of non-small cell lung cancer cells by inhibiting Src/FAK signaling	13
Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis	13
In vivo CART cell imaging: Paving the way for success in CART cell therapy	13
Applications of nuclear-based imaging in gene and cell therapy: Probe considerations	13
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer	13
Oncolytic herpes virus G47Δ injected into tongue cancer swiftly traffics in lymphatics and suppresses metastasis	13
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer	13
Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors	13
LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression	13
DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis	13
Long non-coding RNAs and circular RNAs in tumor angiogenesis: From mechanisms to clinical significance	13
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma	13
R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway	13
miR-124 Intensified Oxaliplatin-Based Chemotherapy by Targeting CAPN2 in Colorectal Cancer	13
Arming HSV-Based Oncolytic Viruses with the Ability to Redirect the Host’s Innate Antiviral Immunity to Attack Tumor Cells	13
A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer	13
Fluorescent imaging for cancer therapy and cancer gene therapy	12
miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma	12
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers	12
Dual Inhibition of MAPK and JAK2/STAT3 Pathways Is Critical for the Treatment of BRAF Mutant Melanoma	12
Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression	12
Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II	12
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer	12
The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth	12
Inhibition of Cholesterol Esterification Enzyme Enhances the Potency of Human Chimeric Antigen Receptor T Cells against Pancreatic Carcinoma	12
Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells	12
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models	12
Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer	12
Comprehensive landscape of tRNA-derived fragments in lung cancer	12
Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody	12
CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway	12
LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer	12
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model	12
A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer	12
Identification of the Combinatorial Effect of miRNA Family Regulatory Network in Different Growth Patterns of GC	12
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation	12
An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition	12
CD47-targeted cancer immunogene therapy: Secreted SIRPα-Fc fusion protein eradicates tumors by macrophage and NK cell activation	12
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma	12
Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer	11
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures	11
Non-coding RNAs and glioma: Focus on cancer stem cells	11
Overexpression of miR-382 Sensitizes Hepatocellular Carcinoma Cells to γδ T Cells by Inhibiting the Expression of c-FLIP	11
Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma	11
Non-coding RNAs in melanoma: Biological functions and potential clinical applications	11
Introducing a new reporter gene, membrane-anchored Cypridina luciferase, for multiplex bioluminescence imaging	11
RBFOX1 Regulates the Permeability of the Blood-Tumor Barrier via the LINC00673/MAFF Pathway	11
Tumor Control by Cytomegalovirus: A Door Open for Oncolytic Virotherapy?	11
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC	11
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer	11
Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response	11
Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells	11
Novel two-chain structure utilizing KIRS2/DAP12 domain improves the safety and efficacy of CAR-T cells in adults with r/r B-ALL	11
Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity	11
Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis	10
Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes	10
Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer	10
Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA	10
G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3	10
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide	10
RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1	10
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma	10
Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms	10
Quantitative proteomics characterization of cancer biomarkers and treatment	10
hsa_circ_0085539 Promotes Osteosarcoma Progression by Regulating miR-526b-5p and SERP1	10
PROTACs in gastrointestinal cancers	10
A Small Molecule Inhibitor, OGP46, Is Effective against Imatinib-Resistant BCR-ABL Mutations via the BCR-ABL/JAK-STAT Pathway	10